D7063ZZ
Beam Radiation Lymphatics, Abdomen to None with None, Electrons Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 6 Lymphatics, Abdomen |
| Approach | 3 Electrons |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Lymphatics, Abdomen
Abdominal lymphatics, including the para-aortic and mesenteric nodal chains, drain abdominal viscera and are targeted when lymphoma, testicular cancer, or other malignancies spread to retroperitoneal nodes. Beam radiation in this region is constrained by numerous radiosensitive structures in close proximity, including the kidneys, spinal cord, small bowel, and liver, making bowel toxicity a principal planning concern and often prompting techniques that limit the volume of small intestine within the field. Treatment extent, whether limited to para-aortic nodes or extended to include additional chains, depends on staging and the pattern of nodal spread. Because abdominal contents shift with patient positioning and bowel filling, simulation often accounts for day-to-day variability, and documentation should specify the nodal region treated within the abdomen.
Modality Qualifier: Electrons
Electrons identifies electron-beam therapy, which delivers a rapid dose falloff after a limited depth and is favored for superficial tumors, skin cancers, or boosts near the surface such as chest wall or scar treatment. Unlike Photons >10 MeV, which continue depositing dose deep into tissue, electrons spare underlying structures once their range is exhausted, making them the modality of choice when sparing deeper organs matters more than penetration.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.